Skip to main content
Drimble Illinois

AbbVie makes $63B bid for Botox maker Allergan

AbbVie is buying Botox maker Allergan in a cash-and-stock deal valued at around $63 billion.The maker of the blockbuster immune disorder treatment Humira...

More from Illinois Non-Local Sources